Société Mineralys Therapeutics, Inc.
Actions
MLYS
US6031701013
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
12,2 USD | -0,25% | -6,15% | +41,86% |
Métier
Nombre d'employés: 28
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jon Congleton
CEO | Chief Executive Officer | 60 | 01/11/20 |
Adam Levy
DFI | Director of Finance/CFO | 46 | 01/03/22 |
Jessica Ibbitson
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
David Rodman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/21 |
Minji Kim
PRN | Corporate Officer/Principal | - | 04/01 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 56 | 01/02/21 | |
Glenn Sblendorio
BRD | Director/Board Member | 68 | 13/09/23 |
Daphne Karydas
BRD | Director/Board Member | 49 | 13/09/23 |
Olivier Litzka
BRD | Director/Board Member | 56 | 08/05/22 |
Jon Congleton
CEO | Chief Executive Officer | 60 | 01/11/20 |
Derek DiRocco
BRD | Director/Board Member | 43 | 08/05/22 |
BT Slingsby
FOU | Founder | 47 | 31/05/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 49 648 540 | 43 426 364 ( 87,47 %) | 0 | 87,47 % |
Coordonnées société
Mineralys Therapeutics, Inc.
150 North Radnor Chester Road Suite F200
19087, Radnor
+
http://www.mineralystx.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+41,86% | 606 M | |
+67,53% | 63,85 Md | |
-0,77% | 41,83 Md | |
+45,66% | 40,65 Md | |
-10,72% | 27,12 Md | |
+13,30% | 26,52 Md | |
-22,79% | 18,69 Md | |
+4,70% | 12,73 Md | |
+24,10% | 12,11 Md | |
+27,41% | 12,07 Md |
- Bourse
- Actions
- Action MLYS
- Société Mineralys Therapeutics, Inc.